KRAS and breast carcinoma: The eight-gene signature was also associated with poor survival in PDAC patients25 (Fig. 1f), whereas no association with patient survival was observed in other tumours where KRAS mutations are rarely found or absent such as squamous cell lung carcinoma or breast cancer (Supplementary Fig. 1q,r).